Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.09.02.610902

FaPDA: Facial paralysis detection algorithm applied in mice

Abstract

Facial paralysis is characterized by an injury to the facial nerve, causing the loss of the functions of the structures that it innervates and changes in the central nervous system in the motor cortex. Therefore, it is important to use experimental models to further the neurophysiological study. Currently, the models have some limitations for the study of facial paralysis. Therefore, the development of an algorithm capable of automatically detecting facial paralysis and overcoming the existing limitations is proposed. C57/BL6 mice were used, which produced irreversible facial paralysis with permanent effects and reversible facial paralysis, where the effects of the paralysis disappear within the first 15 days after the nerve injury. Video recordings were made of the faces of paralyzed mice to develop the algorithm for detecting facial paralysis applied to mice, which allows us to detect the presence of reversible and irreversible facial paralysis automatically. At the same time, the algorithm was used to track facial movement during oral stimulation with sucrose and extracellular electrophysiological recordings in the anterolateral motor cortex. In the basal state, mice can make facial expressions associated with a pleasurable state, and the algorithm detects this movement; at the same time, the movement correlates with the activation in the cortical area. In the presence of facial paralysis, the algorithm can not detect movement. Therefore, it concludes that the condition exists, and the neuronal activity in the cortex is affected with respect to the evolution of facial paralysis. Therefore, the facial paralysis detection algorithm applied to mice allows deduce the presence of experimental facial paralysis, in the presence of oral stimulation or without it, at the same time that cortical electrophysiological recordings can be made for the neurophysiological study of facial paralysis. Significance StatementAutomatic detection of facial paralysis by video recording of the face of mice can help to identify the presence of the condition more easily. It can also used to study facial movement, like facial expressions, and their neural correlates in cortical and subcortical strata. This will allow understanding in depth the level of affectation that facial paralysis can produce at the peripheral and central nervous system levels.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Perrusquia-Hernandez, E., Villeda-Arias, D. I., Montes-Angeles, C. D., Andrade-Gonzalez, R. D., Lomeli-Gonzalez, J., Perez-Martinez, I. O.. 2024-09-03. FaPDA: Facial paralysis detection algorithm applied in mice. https://doi.org/10.1101/2024.09.02.610902

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗